Targeting CCR2/5 in the treatment of non-alcoholic...

Expert Opinion on Investigational Drugs 2020 / 01

Targeting CCR2/5 in the treatment of non-alcoholic steatohepatitis (NASH) and fibrosis: opportunities and challenges

Lefere, Sander, Devisscher, Lindsey, Tacke, Frank
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Expert Opinion on Investigational Drugs
DOI:
10.1080/13543784.2020.1718106
Date:
January, 2020
File:
PDF, 704 KB
english, 2020
Conversion to is in progress
Conversion to is failed